Drugs-Generic Industry

Below are the top mid-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at Watson Pharmaceuticals Inc (NYSE: WPI) is $2.06. WPI's ROE for the same period is 7.57%. The trailing-twelve-month earnings per share at...

Below are the top drugs-generic stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) is 33.13%. HITK's revenue for the same period is $219.97 million. The trailing-twelve-month operating margin at Salix...

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Akorn Inc (NASDAQ: AKRX) is 51.57%. AKRX's revenue for the same period is $118.34 million. The trailing-twelve-month profit margin at Hi-Tech Pharmacal Co Inc (...

Below are the top drugs-generic stocks on the NASDAQ in terms of cash. Mylan Inc (NASDAQ: MYL) had $582.87 million in total cash and $5.36 billion in total debt for the latest quarter. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) had $498.23 million in total cash and $335.98 million in total debt...

Below are the top small-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc (NASDAQ: HITK) is 31.34%. HITK's ROE for the same period is 27.69%. The trailing-twelve-month operating margin at Akorn...

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Akorn Inc (NASDAQ: AKRX) is 34.35%. AKRX's profit margin for the same period is 26.40%. The trailing-twelve-month return on equity at Hi-Tech Pharmacal Co...

Below are the top small-cap drugs-generic stocks on the NYSE, the NASDAQ and the AMEX in terms of revenue. The trailing-twelve-month revenue at Pharmaceutical Companies (NYSE: PRX) is $1.01 billion. PRX's ROE for the same period is 16.46%. The trailing-twelve-month revenue at Caraco...

Below are the top small-cap drugs-generic stocks on the NYSE, the NASDAQ and the AMEX in terms of revenue. The trailing-twelve-month revenue at Pharmaceutical Companies (NYSE: PRX) is $1.01 billion. PRX's ROE for the same period is 16.46%. The trailing-twelve-month revenue at Caraco...

Below are the top small-cap drugs-generic stocks on the NYSE and the NASDAQ in terms of cash. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) had $518.03 million in total cash and $323.49 million in total debt for the latest quarter. Pharmaceutical Companies (NYSE: PRX) had $246.54 million in total...

Below are the top drugs-generic stocks on the NASDAQ in terms of cash. Mylan Inc (NASDAQ: MYL) had $641.03 million in total cash for the latest quarter. Meanwhile, MYL's total debt stood at $5.41 billion. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) had $491.47 million in total cash and $319.99 million...

Below are the top drugs-generic stocks on the NYSE, the NASDAQ and the AMEX in terms of cash. Mylan Inc (NASDAQ: MYL) had $641.03 million in total cash and $5.41 billion in total debt for the latest quarter. Watson Pharmaceuticals Inc (NYSE: WPI) had $265.90 million in total cash for the latest...

Below are the top drugs generic stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity for Hi Tech Pharmacal Co Inc (NASDAQ: HITK) is 28.77%. HITK’s quarterly earnings grew 312.40% y/y. The trailing-twelve-month return on equity for Par...

Below are the top drugs generic stocks on the NYSE and the NASDAQ in terms of EPS estimates for the next quarter. Watson Pharmaceuticals Inc (NYSE: WPI) is likely to earn $0.85 in the September quarter. WPI has a PEG ratio of 0.90. Hi Tech Pharmacal Co Inc (NASDAQ: HITK) is expected to earn $0.52...